CO2 LASER

The carbon dioxide laser (CO2) was developed in the 1960’s and is still used in specialized medical applications today. The CO2 laser works especially well with skin deficiencies and has been used with extramammary Paget’s disease (EMPD) patients.

Ablation by CO2 laser can reduce the number of EMPD cells, however, many EMPD patients have found it to be insufficient in achieving complete remission. Scarring is also possible. Some EMPD patients have used a combination of CO2 laser and photodynamic therapy (PDT).

Depending upon the size of the EMPD area involved, some CO2 laser patients require an operating room with the procedure done under sedation.

Treatments for extramammary Paget’s disease (EMPD) often differ but frequently include one or more of the following: Mohs surgery, wide local excision (WLE) surgery, topical creams, carbon dioxide (CO2) laser, photodynamic therapy (PDT), cavitational ultrasonic surgical aspiration (CUSA), radiation therapy, skin grafts, and chemotherapy.

The content on this website, including text and visual materials, is intended to raise awareness of extramammary Paget’s disease (EMPD) and help individuals understand its complexities. However, it is not a substitute for professional medical advice, diagnosis, or treatment, nor does it endorse any specific treatments, tests, physicians, procedures, or products. If you suspect symptoms of EMPD, we encourage you to consult a qualified healthcare provider for proper evaluation and guidance.